Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jan;63(1):104–109. doi: 10.1128/iai.63.1.104-109.1995

Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections.

C Selig 1, W Nothdurft 1
PMCID: PMC172964  PMID: 7528729

Abstract

To investigate the physiological role of granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in the adaptation mechanisms of myelopoiesis to enhanced demand, we studied both cytokines and their myeloid target cells in hematologically healthy patients suffering from acute bacterial infections. Endogenous serum levels of G-CSF and GM-CSF, granulocyte-macrophage colony-forming cell (GM-CFC) concentrations, and differential counts were determined for the peripheral blood of 57 patients with clinically apparent bacterial infections (26 males and 31 females aged 16 to 89 years) and 18 healthy controls (8 males and 10 females aged 23 to 84 years). Patients were selected for acute-phase protein and at least two additional clinical signs reflecting a bacterial infection. Patients showed significantly higher numbers of myeloid progenitor cells than controls (median, 68 versus 26 GM-CFC/ml; P < or = 0.01). G-CSF but not GM-CSF levels were found to be elevated (> or = 50 to 863 pg/ml). In the acute stage of infection, progenitor and cytokine levels were not influenced by gender, differences in therapy, or localization of the infection. Progenitor and G-CSF levels were not associated with absolute neutrophil counts or C-reactive protein. However, a negative correlation between number of GM-CFC per milliliter and age (R = -0.47; P < or = 0.001) and an inverse relationship between the incidence of high GM-CFC concentrations and elevated G-CSF levels (phi = -0.34; P < or = 0.01) were found. Combining both parameters into a cytokine-progenitor pattern, we observed a highly significant age-dependent response of myelopoiesis to inflammation (P < or = 0.001). Younger patients had high progenitor counts (> 75 GM-CFC/ml) associated with G-CSF levels below 50 pg/ml, whereas for the older patients, the reverse pattern was predominant. The results indicate that the age-dependent myelopoietic response to acute bacterial infections is characterized by an inverse relationship between progenitor cells and G-CSF. The observed cytokine-progenitor patterns could have implications for therapy with G-CSF and the prognosis of infectious diseases.

Full Text

The Full Text of this article is available as a PDF (256.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antman K. S., Griffin J. D., Elias A., Socinski M. A., Ryan L., Cannistra S. A., Oette D., Whitley M., Frei E., 3rd, Schnipper L. E. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med. 1988 Sep 8;319(10):593–598. doi: 10.1056/NEJM198809083191001. [DOI] [PubMed] [Google Scholar]
  2. Calandra T., Baumgartner J. D., Grau G. E., Wu M. M., Lambert P. H., Schellekens J., Verhoef J., Glauser M. P. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis. 1990 May;161(5):982–987. doi: 10.1093/infdis/161.5.982. [DOI] [PubMed] [Google Scholar]
  3. Cannistra S. A., Griffin J. D. Regulation of the production and function of granulocytes and monocytes. Semin Hematol. 1988 Jul;25(3):173–188. [PubMed] [Google Scholar]
  4. Cheers C., Haigh A. M., Kelso A., Metcalf D., Stanley E. R., Young A. M. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun. 1988 Jan;56(1):247–251. doi: 10.1128/iai.56.1.247-251.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cruickshank A. M., Fraser W. D., Burns H. J., Van Damme J., Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 1990 Aug;79(2):161–165. doi: 10.1042/cs0790161. [DOI] [PubMed] [Google Scholar]
  6. DeLamarter J. F. Hemopoietic colony stimulating factors. A physiological and pharmacological role in fighting infection? Biochem Pharmacol. 1988 Aug 15;37(16):3057–3062. doi: 10.1016/0006-2952(88)90301-2. [DOI] [PubMed] [Google Scholar]
  7. Dörmer P., Hültner L., Mergenthaler H. G. Proliferation and maturation of human bone marrow cells in infectious diseases. Pathol Res Pract. 1990 Feb;186(1):145–149. doi: 10.1016/S0344-0338(11)81022-8. [DOI] [PubMed] [Google Scholar]
  8. Hyde S. R., McCallum R. E. Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect Immun. 1992 Mar;60(3):976–982. doi: 10.1128/iai.60.3.976-982.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kawakami M., Tsutsumi H., Kumakawa T., Abe H., Hirai M., Kurosawa S., Mori M., Fukushima M. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990 Nov 15;76(10):1962–1964. [PubMed] [Google Scholar]
  10. Kawakami M., Tsutsumi H., Kumakawa T., Hirai M., Kurosawa S., Mori M., Fukushima M. Serum granulocyte colony-stimulating factor in patients with repeated infections. Am J Hematol. 1992 Nov;41(3):190–193. doi: 10.1002/ajh.2830410309. [DOI] [PubMed] [Google Scholar]
  11. Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992 Jul 2;327(1):28–35. doi: 10.1056/NEJM199207023270106. [DOI] [PubMed] [Google Scholar]
  12. MacVittie T. J., Monroy R. L., Patchen M. L., Souza L. M. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol. 1990 Apr;57(4):723–736. doi: 10.1080/09553009014550891. [DOI] [PubMed] [Google Scholar]
  13. Mackensen A., Galanos C., Engelhardt R. Treatment of cancer patients with endotoxin induces release of endogenous cytokines. Pathobiology. 1991;59(4):264–267. doi: 10.1159/000163659. [DOI] [PubMed] [Google Scholar]
  14. McCarthy D. M., Goldman J. M. Transfusion of circulating stem cells. Crit Rev Clin Lab Sci. 1984;20(1):1–24. doi: 10.3109/10408368409165768. [DOI] [PubMed] [Google Scholar]
  15. Mertelsmann R., Herrmann F., Hecht T., Schulz G. Hematopoietic growth factors in bone marrow transplantation. Bone Marrow Transplant. 1990 Aug;6(2):73–77. [PubMed] [Google Scholar]
  16. Metcalf D. The role of the colony-stimulating factors in resistance to acute infections. Immunol Cell Biol. 1987 Feb;65(Pt 1):35–43. doi: 10.1038/icb.1987.4. [DOI] [PubMed] [Google Scholar]
  17. Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988 Mar 26;1(8587):667–672. doi: 10.1016/s0140-6736(88)91475-4. [DOI] [PubMed] [Google Scholar]
  18. Nothdurft W., Selig C., Fliedner T. M., Hintz-Obertreis P., Kreja L., Krumwieh D., Kurrle R., Seiler F. R., Weinsheimer W. Haematological effects of rhGM-CSF in dogs exposed to total-body irradiation with a dose of 2.4 Gy. Int J Radiat Biol. 1992 Apr;61(4):519–531. doi: 10.1080/09553009214551281. [DOI] [PubMed] [Google Scholar]
  19. Omori F., Okamura S., Shimoda K., Otsuka T., Harada M., Niho Y. Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions. Biotherapy. 1992;4(2):147–153. doi: 10.1007/BF02171759. [DOI] [PubMed] [Google Scholar]
  20. Rothstein G., Christensen R. D., Nielsen B. R. Kinetic evaluation of the pool sizes and proliferative response of neutrophils in bacterially challenged aging mice. Blood. 1987 Dec;70(6):1836–1841. [PubMed] [Google Scholar]
  21. Rothstein G. Hematopoiesis in the aged: a model of hematopoietic dysregulation? Blood. 1993 Nov 1;82(9):2601–2604. [PubMed] [Google Scholar]
  22. Sallerfors B., Olofsson T., Lenhoff S. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients. Bone Marrow Transplant. 1991 Sep;8(3):191–195. [PubMed] [Google Scholar]
  23. Sashida M. [Mechanism of stimulation of spleen mononuclear cells by gram-positive bacterial peptidoglycan]. Nichidai Koko Kagaku. 1989 Sep;15(3):196–206. [PubMed] [Google Scholar]
  24. Shirafuji N., Asano S., Matsuda S., Watari K., Takaku F., Nagata S. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders. Exp Hematol. 1989 Feb;17(2):116–119. [PubMed] [Google Scholar]
  25. Watari K., Asano S., Shirafuji N., Kodo H., Ozawa K., Takaku F., Kamachi S. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989 Jan;73(1):117–122. [PubMed] [Google Scholar]
  26. Whetton A. D., Dexter T. M. Myeloid haemopoietic growth factors. Biochim Biophys Acta. 1989 Dec 17;989(2):111–132. doi: 10.1016/0304-419x(89)90038-3. [DOI] [PubMed] [Google Scholar]
  27. Williams M. E., Quesenberry P. J. Hematopoietic growth factors. Hematol Pathol. 1992;6(3):105–124. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES